Impact BioMedical Inc.
IBO
$0.58
$0.00-0.46%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31,100.00% | 65,800.00% | 199,800.00% | 1,227.36% | -33.33% |
| Total Receivables | -23.95% | -38.37% | -44.41% | -52.67% | -11.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 307.14% | 8,500.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 382.41% | 551.64% | 637.35% | 533.73% | -11.78% |
|
|
|||||
| Total Current Assets | 382.41% | 551.64% | 637.35% | 533.73% | -11.78% |
| Net Property, Plant & Equipment | -95.07% | -94.39% | -94.08% | -2.42% | -2.07% |
| Long-term Investments | -- | -- | -- | 0.00% | 0.00% |
| Goodwill | -- | -- | -- | 0.00% | 0.00% |
| Total Other Intangibles | -4.36% | -4.24% | -5.88% | -5.80% | -5.71% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -56.80% | -54.80% | -54.54% | 3.58% | -4.07% |
|
|
|||||
| Total Accounts Payable | -43.81% | -39.88% | -14.30% | 110.29% | 227.57% |
| Total Accrued Expenses | 336.07% | 361.70% | -15.65% | 1,600.00% | -- |
| Short-term Debt | 66.16% | -28.51% | -26.76% | -- | 14.45% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 59.82% | -28.03% | -25.51% | -90.72% | 20.27% |
|
|
|||||
| Total Current Liabilities | 59.82% | -28.03% | -25.51% | -90.72% | 20.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 66.16% | -28.51% | -26.76% | -- | 14.45% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.02% | 1.02% | 1.02% | 0.00% | 0.00% |
| Total Liabilities | 49.09% | -22.53% | -20.27% | -20.37% | 15.98% |
|
|
|||||
| Common Stock & APIC | 12.48% | 12.06% | 9.82% | 9.60% | -0.16% |
| Retained Earnings | -259.78% | -179.65% | -190.63% | 9.49% | -40.19% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -144.61% | -84.37% | -83.31% | 18.00% | -15.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | -144.61% | -84.37% | -83.31% | 18.00% | -15.59% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -1.60% | -1.23% | -2.04% | -2.05% | -2.34% |
| Total Equity | -127.97% | -75.02% | -74.39% | 16.13% | -14.07% |
|
|
|||||